Literature DB >> 2606675

Biologically motivated models for chemical risk assessment.

H J Clewell1, M E Andersen.   

Abstract

Assessing the risk associated with human exposure to environmental chemicals depends to a large extent on the ability to extrapolate from a particular range of exposure conditions in the test animal species to a very different range of exposure conditions in the human. One of the more promising tools for accomplishing this extrapolation is the biologically motivated pharmacokinetic/pharmacodynamic model. In a biologically motivated model, the structure is based on the physiological and biochemical structure of the animal system being described. This paper provides an overview of the biologically motivated modeling approach. Examples of models for styrene and methylene chloride are discussed in relation to their ability to predict human kinetics for these chemicals and their use in estimating the risk of chemicals to exposed humans. Finally, the use of a biologically motivated model to analyze the mechanistic basis of chemical carcinogenesis is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2606675     DOI: 10.1097/00004032-198907001-00016

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  2 in total

1.  A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment.

Authors:  Harvey J Clewell; Melvin E Andersen; Hugh A Barton
Journal:  Environ Health Perspect       Date:  2002-01       Impact factor: 9.031

Review 2.  Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.

Authors:  H J Clewell; P R Gentry; T R Covington; J M Gearhart
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.